The experience of having a diagnosis of Parkinson’s in the family, finding out about research opportunities and taking part in a study. Presented by Dr. Sue Whipps and Professor John Whipps, founder members of PenPRIG.
In recent years it has become clear that genetics plays a key role in the development of Parkinson’s. By understanding genetic pathways, the hope is that a novel drug to prevent or slow down Parkinson’s development can be produced.
One of the most common genes implicated in Parkinson’s disease is glucocerebrosidase (GBA). About 10% of UK Parkinson’s patients carry a mutation in this gene. In this 25-minute video “From genes to therapy” , Dr. Stephen Mullin described how this gene causes Parkinson’s disease, and outlined some exciting recent advances in drug development.
Dr. Mullin holds a clinical lectureship in Neurology at The Faculty of Medicine and Dentistry at Plymouth University.
Thwarted by the Covid-19 lockdown , PenPRIG took its “Meet The Researcher” event planned to take place at The Maltsters Arms, Woodbury on 25th March 2020, into the digital world courtesy of Zoom.
Claire Bale of Parkinson’s UK talked to us and fielded questions that we had gathered from those who had tickets to be there courtesy of Eventbrite.
This is the video transcript of the 15 minute presentation and the 25 minute Q and A session. We hope you find it informative and a good use of time you may have on your hands for a little while yet.